Cellular uptake of [¹⁴C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA. by Takuro Iwao (14636741)

Taste sensilla in the wing and RNA-seq screen of control and <i>Poxn</i> wings. by Zhe He (508742)

Fermentation must reducing sugar (A, strain A; B, strain B; C, strain F) and fermentation ethanol concentration (D, strain A; E, strain B; F, strain F) for <i>S. cerevisiae</i> str... by Xiang-yu Sun (748032)

Deleting NspA decreases binding of fH to <i>N. meningitidis</i>. by Lisa A. Lewis (244867)

Old rat serum present higher levels of pro-inflammatory cytokine. by María Paz Saldías (4430032)

Total Slo expression and more significantly, surface clusters of Slo on the surface of hair cells are decreased with β-catenin knockdown. by Shumin Bian (191969)

HAOSMCs lacking CD9 display altered actin arrangement and a decrease in active RhoA and collagen gel contraction. by Michael J. Herr (428546)

C2GnT1 gene knockdown decreases C2-O-sLe^X glycoproteins and C2GnT1 activity. by Catherine A. St. Hill (357388)

“…Note the absence of a detected C2GnT1 protein 50 kDa band. (D) We observed a 30–40% decrease in reactivity with CHO-131 mAb by flow cytometry for LS174T and HepG2 cells that contained C2GnT1 shRNA. …”

Summary of cell-based assay EC50 results for WT BMP9 and A347E variant. by Tobias G. Schips (21799838)

Chemical inhibition of formins decreases actin pedestal assembly by EPEC, but not by KC12+EspF_U. by Katrina B. Velle (4330957)

U87MG glioma cells transduced with gal-3 shRNA demonstrate decreased tumor size and growth. by Rafael Yamashita Ikemori (698128)

“…<p>U87MG cells transduced with gal-3 shRNA demonstrated decreased gal-3 protein by western blot (<b><i>A</i></b>) and mRNA by qRT-PCR (<b><i>B</i></b>) compared to scramble shRNA. …”

Inhibition of GLS1 decreases the proportion of CCR6 and CXCR3 expressing CD4⁺ T cells. by Zeynep Sener (3146064)

“…Data points in panels B-E represent results from three different donors (n = 3, Mean ± SD, ****p˂0.001, ***p˂0.005, **p˂0.01)</p>…”

Female EIIIA-cFN null mice have decreased accumulation of intracellular lipids at day 2 after PHx. by Bridget Sackey-Aboagye (3221319)

“…Oil Red O staining was decreased in female EIIIA-cFN null mice <b>(B)</b> in comparison to wild type littermates <b>(A)</b>. …”

Taste bud cell populations are decreased after <i>Sox2</i> deletion in epithelial stem/progenitor cells. by Makoto Ohmoto (3065106)

The RsW50 of regulatory spleen cells is decreased by enriching for CD8⁺ regulatory spleen cells. by Roshanak Sharafieh (311047)

Adaptation to cool temperature decreases basal and stimulated lipolysis and increases <i>de novo</i> lipogenesis and TAG synthesis. by Hiroyuki Mori (512656)

“…<i>n =</i> 5, data are mean ± SD. *<i>p</i> < 0.05. Uncropped western blots are provided in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3000988#pbio.3000988.s016" target="_blank">S1 Raw Images</a>, and numerical data for all graphs are provided in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3000988#pbio.3000988.s014" target="_blank">S6 Data</a>. …”

Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

“…<b>(B)</b> A significant decrease in the proliferative clonal capacity of U251MG colonies was observed with 50ΜM and 100ΜM SHG-44 treatment. …”

Capsaicin, pyridoxine, vincristine sulfate and ionomycin significantly decreased axon length ratio but only pyridoxine had no impact on neurotoxicity. by Fei San Lee (17282886)

“…<p>DRG axon length ratio to pre-treat measured on days 1, 2 and 3 after axonal dieback compound screening with (<b>A</b>) Caps, (<b>C</b>) Pyr, (<b>E</b>) Vcr and (<b>G</b>) Imy in male (left) and female (right) rat DRG explants were compared over time (#p<0.05) and between respective solvent controls (⁕p<0.05). …”

IFNAR1 is decreased on CD103⁺ DCs in the PPs of mice following treatment with La-IFN-β. by Adelle P. McFarland (229619)

ChAT knock-down using an antisense oligodeoxynucleotide (AS-ODN) against ChAT, and decreased expression of ChAT in the DRG and spinal cord by Misaki Matsumoto (52354)